PetroBras Bear Braces for Aftershock – Buys Ratio Put Spread

Today’s tickers: PBR, HOG, BMY, FXE, KFT, YHOO, MOS, NTGR, BIDU & DIS PBR – Petroleo Brasileiro SA ADR – Shares of Brazil’s state-owned oil and natural gas company rose 1.20% to $40.02 this afternoon, adding to the nearly 8% recovery in shares since Friday February 5, 2010, up to an intraday high of $40.25. But, painfully recent memories of the nearly 30% decline in the price per PBR-share from $52.88 on December 1, 2009, to a six-month low of $37.31 on February 8, 2010, have one investor casting doubts that this week’s rebound in shares will last. The investor initiated a ratio put spread to hedge against further share price erosion through February expiration. The trader bought 10,000 puts at the February $39 strike for a premium of $0.50 apiece, and sold 20,000 puts at the lower February $36 strike for a premium of $0.10 each. The net cost of the pessimistic play amounts to $0.30 per contract. Thus, the investor is positioned to amass profits should PBR’s shares slip beneath the breakeven price of $38.70 by expiration day. Maximum potential profits of $2.70 per contract are available to the trader if PetroBras’ share price falls 10% from the current price of $40.02 to reach $36.00 by expiration next Friday. HOG – Harley-Davidson, Inc. – The motorcycle manufacturer’s shares declined 0.25% to $22.67 today prompting pessimistic options trades in the March contract. Investors purchased put spreads to position for potential share price erosion through expiration next month. Approximately 12,500 puts were picked up at the March $22 strike for an average premium of $1.08 apiece, spread against the sale of 12,500 puts at the lower March $19 strike for a premium of $0.25 each. The debit put spreads cost traders a net $0.83 per contract. Maximum potential profits of $2.17 per contract accumulate for put-spreaders if HOG’s share price plummets more than 16% from the current value of the stock to reach $19.00 by expiration. BMY – Bristol-Myers Squibb Co. – Pharmaceutical company, Bristol-Myers Squibb, attracted bullish options traders today despite the 1.25% decline in the price of its shares to $23.94. One investor is optimistic that BMY’s shares will rally approximately 9% in the next five months to June expiration. The trader purchased a debit call spread to position for potential bullish movement in the price of the underlying stock. It appears the investor purchased 5,900 calls at the June $24 strike for a…